This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Lux MP, Benedict A, Buchholz S, Woeckel A, Harbeck N, Kreienberg R, Kaufmann M, Beckmann MW, Jonat W, Hadji P, Distler W, Raab G, Tesch H, Weyers G, Schneeweiss A, Possinger K.Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy in early breast cancer - a German health economic analysis. 31st Annual San Antonio Breast Cancer Symposium: abstr. 6109, 10 Dec 2008. Available from: URL: http://www.sabcs.saci.org
Rights and permissions
About this article
Cite this article
Anastrozole wins out over tamoxifen for breast cancer. Pharmacoecon. Outcomes News 570, 4 (2009). https://doi.org/10.2165/00151234-200905700-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905700-00010